Literature DB >> 17682977

Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.

Jeffrey B Schwimmer1.   

Abstract

This review covers the diagnosis and epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in children and adolescents. Pediatric NAFLD remains a clinicopathologic diagnosis requiring direct demonstration of liver steatosis and the exclusion of other causes of fatty liver and/or hepatitis. NAFLD is the most common cause of chronic liver disease in children. The number of children with NAFLD presents a major public health crisis. Age, sex, race, ethnicity, and body habitus all influence the risk for NAFLD. The epidemiology of pediatric NAFLD should inform future attempts to develop rigorously evaluated screening protocols. Moreover, these data should guide efforts to delineate the pathophysiology in children and adolescents. Our future ability to prevent and treat pediatric NAFLD is dependent upon such work.

Entities:  

Mesh:

Year:  2007        PMID: 17682977     DOI: 10.1055/s-2007-985075

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  27 in total

Review 1.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Sandra K Erickson
Journal:  J Lipid Res       Date:  2008-12-12       Impact factor: 5.922

Review 3.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

4.  Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.

Authors:  Jens-Peter Kühn; Diego Hernando; Birger Mensel; Paul C Krüger; Till Ittermann; Julia Mayerle; Norbert Hosten; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

Review 5.  Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.

Authors:  Andrea Tannapfel; Helmut Denk; Hans-Peter Dienes; Cord Langner; Peter Schirmacher; Michael Trauner; Berenike Flott-Rahmel
Journal:  Virchows Arch       Date:  2011-03-26       Impact factor: 4.064

6.  Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ronald J Sokol; Kelley E Capocelli; Zhaoxing Pan; Jillian S Sullivan; Kristen Robbins; Ann C Halbower
Journal:  J Pediatr       Date:  2013-12-07       Impact factor: 4.406

7.  Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.

Authors:  Jennifer L Rehm; Peter M Wolfgram; Diego Hernando; Jens C Eickhoff; David B Allen; Scott B Reeder
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

8.  Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery.

Authors:  Perrie E Pardee; Joel E Lavine; Jeffrey B Schwimmer
Journal:  Semin Pediatr Surg       Date:  2009-08       Impact factor: 2.754

9.  Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

Authors:  Peter Bannas; Harald Kramer; Diego Hernando; Rashmi Agni; Ashley M Cunningham; Rakesh Mandal; Utaroh Motosugi; Samir D Sharma; Alejandro Munoz del Rio; Luis Fernandez; Scott B Reeder
Journal:  Hepatology       Date:  2015-09-28       Impact factor: 17.425

10.  Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease.

Authors:  K D Kistler; J Molleston; A Unalp; S H Abrams; C Behling; J B Schwimmer
Journal:  Aliment Pharmacol Ther       Date:  2009-10-23       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.